EKOSONIC
Device
EKOS Corporation
Total Payments
$5.4M
Transactions
14,932
Doctors
6,855
Companies
8
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $96,908 | 2 | 0 |
| 2021 | $43,238 | 963 | 733 |
| 2020 | $882,560 | 537 | 138 |
| 2019 | $1.6M | 3,748 | 2,123 |
| 2018 | $1.5M | 5,383 | 2,942 |
| 2017 | $1.3M | 4,299 | 2,733 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.1M | 1,099 | 58.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $755,406 | 206 | 14.1% |
| Food and Beverage | $587,515 | 12,785 | 11.0% |
| Travel and Lodging | $300,040 | 711 | 5.6% |
| Consulting Fee | $253,021 | 85 | 4.7% |
| Grant | $193,780 | 11 | 3.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $73,402 | 17 | 1.4% |
| Space rental or facility fees (teaching hospital only) | $73,250 | 4 | 1.4% |
| Education | $1,341 | 14 | 0.0% |
Payments by Type
Research
$3.1M
1,099 transactions
General
$2.2M
13,833 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| KNOCOUT PE | EKOS Corporation | $810,954 | 0 |
| PE Study PE Optylase | EKOS Corporation | $718,625 | 0 |
| KNOCOUT PE | BOSTON SCIENTIFIC CORPORATION | $495,424 | 0 |
| PE Study PE Optalyse | EKOS Corporation | $339,907 | 0 |
| PE Study (PE) / Optalyse | BOSTON SCIENTIFIC CORPORATION | $202,048 | 0 |
| Access Study | EKOS Corporation | $171,719 | 0 |
| PE Study (PE) / Optalyse | Boston Scientific Corporation | $137,136 | 0 |
| PE Study PE Seattle II | EKOS Corporation | $95,926 | 0 |
| A Clinical Study of Patients with PE Receiving Anticoagulation Along and a Similar Analysis of the OPTALYSEPE Trial BLUSH II & III | BOSTON SCIENTIFIC CORPORATION | $80,340 | 0 |
| Fibrinolytic deficit in patients with acute pulmonary embolism | BOSTON SCIENTIFIC CORPORATION | $16,568 | 0 |
| Roxwood CTO | BOSTON SCIENTIFIC CORPORATION | $15,325 | 0 |
| Speek Study | EKOS Corporation | $12,596 | 0 |
| Roxwood CTO | EKOS Corporation | $7,711 | 0 |
| KNOCOUT PE | Boston Scientific Corporation | $6,884 | 2 |
| Roxwood CTO | Boston Scientific Corporation | $5,000 | 0 |
Top Doctors Receiving Payments for EKOSONIC — Page 275
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Lafayette, LA | $2.96 | 1 |
| , D.O | Internal Medicine | Oklahoma City, OK | $2.62 | 1 |
| , D.O | Vascular & Interventional Radiology | Newark, DE | $2.52 | 1 |
| , MD | Diagnostic Radiology | Charlotte, NC | $2.50 | 1 |
| , M.D | Cardiovascular Disease | Thorndale, PA | $2.04 | 1 |
| , M.D., M.S | Vascular & Interventional Radiology | Cincinnati, OH | $1.68 | 1 |
Ad
Manufacturing Companies
- EKOS Corporation $4.3M
- BOSTON SCIENTIFIC CORPORATION $846,997
- Boston Scientific Corporation $175,708
- Biocompatibles, Inc. $16,617
- BTG International, Inc. $15,368
- Biocompatibles UK Ltd $2,841
- PneumRx, Inc $535.00
- BTG International Canada Inc. $161.05
Product Information
- Type Device
- Total Payments $5.4M
- Total Doctors 6,855
- Transactions 14,932
About EKOSONIC
EKOSONIC is a device associated with $5.4M in payments to 6,855 healthcare providers, recorded across 14,932 transactions in the CMS Open Payments database. The primary manufacturer is EKOS Corporation.
Payment data is available from 2017 to 2022. In 2022, $96,908 was paid across 2 transactions to 0 doctors.
The most common payment nature for EKOSONIC is "Unspecified" ($3.1M, 58.2% of total).
EKOSONIC is associated with 15 research studies, including "KNOCOUT PE" ($810,954).